bio-metabolomics-analysis-pharmacometabolomics

Identify drug-induced metabolite changes and predict metabolic pathways from LC-MS datasets.

7|Updated Apr 5, 2026
One-click install
npx skills add https://github.com/dailycafi/metabolism-skills --skill bio-metabolomics-analysis-pharmacometabolomics
Or copy as Structured Prompt for Agent
Please help me install this Agent Skill.
Skill: bio-metabolomics-analysis-pharmacometabolomics
Source: https://github.com/dailycafi/metabolism-skills/tree/main/skills/metabolomics-analysis/pharmacometabolomics
Command: npx skills add https://github.com/dailycafi/metabolism-skills --skill bio-metabolomics-analysis-pharmacometabolomics

SYSTEM DOCUMENTATION & REQUIREMENTS

What problem does it solve?

This Skill helps researchers identify drug-related metabolic changes, predict likely metabolic pathways and enzyme interactions, and prioritize putative metabolites from LC‑MS data and molecular structures to accelerate pharmacometabolomics studies.

Core Features & Use Cases

  • Paired drug response analysis: statistical comparison of pre-dose and post-dose metabolomics with multiple testing correction and visualization.
  • CYP450 substrate prediction: compute RDKit descriptors and apply rule-based heuristics to rank likely metabolizing isoforms.
  • ADME estimation and metabolic soft spots: Lipinski/Veber checks, ESOL solubility estimation, and atom-level soft-spot detection for oxidation and dealkylation.
  • Phase I/II metabolite search in LC‑MS: compute expected m/z shifts for common biotransformations and search experimental mz/rt tables within ppm tolerance.
  • DrugBank and PK/PD integration: retrieve enzyme and metabolite annotations via DrugBank API (requires API key) and correlate PK parameters (AUC, Cmax, Tmax) with metabolite levels.
  • R integration with MetaboAnalystR: end-to-end differential analysis, normalization, volcano plots, and PLS-DA for responder vs non-responder studies.
  • Use Case: Compare paired metabolomics from a clinical dosing study to detect drug-responsive metabolites, predict responsible CYP isoforms, and validate candidates with MS/MS and DrugBank annotations.

Quick Start

Use the pharmacometabolomics skill to compare pre-dose and post-dose metabolomics CSV files and produce a ranked list of significant drug-associated metabolites.

Frequently Asked Questions about bio-metabolomics-analysis-pharmacometabolomics

High-intent search queries and answers about installing and using this skill.

FAQPage Schema
How do I predict drug metabolism pathways and CYP450 substrates from molecular structures?

Predict drug metabolism pathways by computing RDKit molecular descriptors and applying rule-based heuristics to rank likely CYP450 metabolizing isoforms from your input molecular structures.

How do I search LC-MS datasets for Phase I and Phase II metabolites?

Search LC-MS datasets for Phase I and II metabolites by computing expected m/z shifts for common biotransformations and matching experimental mz/rt tables within specified ppm tolerances.

Can I compare pre-dose and post-dose metabolomics data to identify drug-responsive metabolites?

Compare pre-dose and post-dose metabolomics CSV files using statistical testing with multiple testing correction to detect and rank significant drug-responsive metabolites.

Do I need a DrugBank API key to retrieve enzyme and metabolite annotations?

A DrugBank API key is required to retrieve enzyme and metabolite annotations, enabling you to validate putative metabolites and correlate PK parameters like AUC and Cmax with metabolite levels.

What's the best way to identify metabolic soft spots for oxidation and dealkylation?

Identify metabolic soft spots by running Lipinski/Veber checks and ESOL solubility estimation to perform atom-level soft-spot detection specifically for oxidation and dealkylation reactions.

Does this pharmacometabolomics workflow integrate with R for differential analysis?

The workflow integrates with R using MetaboAnalystR to perform end-to-end differential analysis, normalization, volcano plots, and PLS-DA for responder versus non-responder studies.